TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
8,541
|
8,592 | |
Financial expenses |
0
|
1 | |
Earnings before taxes |
229
|
118 | |
EBITDA |
235
|
130 | |
Total assets |
3,388
|
3,488 | |
Current assets |
3,368
|
3,462 | |
Current liabilities |
945
|
1,197 | |
Equity capital |
2,276
|
2,128 | |
- share capital |
36
|
37 | |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
67.2%
|
61.0% | |
Turnover per employee |
2,847
|
2,864 | |
Profit as a percentage of turnover |
2.7%
|
1.4% | |
Return on assets (ROA) |
6.8%
|
3.4% | |
Current ratio |
356.4%
|
289.2% | |
Return on equity (ROE) |
10.1%
|
5.5% | |
Change turnover |
74
|
119 | |
Change turnover % |
7%
|
1%
![]() |
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.